Tempest Therapeutics, Inc.
TPST
$6.87
$0.385.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.81M | -10.56M | -9.57M | -7.90M | -7.49M |
| Total Depreciation and Amortization | 49.00K | 97.00K | 155.00K | 88.00K | 85.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.64M | 1.64M | 1.73M | 1.81M | 1.57M |
| Change in Net Operating Assets | 1.98M | -1.36M | 2.18M | -1.18M | -343.00K |
| Cash from Operations | -10.15M | -10.18M | -5.51M | -7.19M | -6.18M |
| Capital Expenditure | -3.00K | -15.00K | -249.00K | -168.00K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -15.00K | -249.00K | -168.00K | -7.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.20M | -2.20M | -- | -- | -- |
| Issuance of Common Stock | 20.15M | 3.74M | 4.56M | 450.00K | 34.35M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.95M | 1.54M | 4.56M | 450.00K | 34.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.80M | -8.66M | -1.20M | -6.90M | 28.17M |